Schedule 13D ownership disclosure

NextCure Inc

Common Stock, $0.001 par value · CUSIP: 65343E207

Event date: 2025-12-19

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Sofinnova Venture Partners IX, L.P. ("SVP IX")Reported CIK 0001612133

    Shares: 222,654.00 · Class: 7.1%

  • Sofinnova Management IX, L.L.C. ("SM IX")

    Shares: 222,654.00 · Class: 7.1%

  • Dr. James I. Healy ("Healy")

    Shares: 222,654.00 · Class: 7.1%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-26-023741
Form type
SCHEDULE 13D/A
Filer
NextCure, Inc.
CIK
CIK 1661059
Filed
Mar 05, 2026
Reporting period
Dec 19, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub